PlexusDx Reviews OrderlyMeds GLP-1 Dose Pricing Claims
The consumer-facing analysis compares evidence found on OrderlyMeds dose pricing against what could not be verified.
MH
By Maren Holt · Senior Reporter, GLP-1
Sep 15 15:51 ETSource: PlexusDx
The wire
- 01PlexusDx published a review of OrderlyMeds GLP-1 dose pricing claims.
- 02Direct-to-consumer GLP-1 pricing transparency is a growing patient concern.
- 03Details of verification methods and findings are not specified in the source.
From the source
Read at news.google.comOrderlyMeds GLP-1 Dose Pricing: Evidence We Found vs What We Can